Connect with others who understand.

Sign up Log in
Quick Links
Q&A Treatments A-Z Help Center Community guidelines Crisis Accessibility
Resources
Emotional Well-Being Living with Myeloma Myeloma Condition Information Myeloma Symptoms Myeloma Treatments All Resources
About MyMyelomaTeam
What is MyMyelomaTeam Terms of Use Privacy policy
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

I Was Just Informed That I Have A T14-16 Mutation And That Puts Me At High Risk. This Sounds Very Scary - Does Anyone Know More About It?

A MyMyelomaTeam Member asked a question 💭
Cincinnati, OH
June 27
•
Be the first to like/hug
A MyMyelomaTeam Member

Thank you, I am scheduled to see a specialist on July 15th.

July 1
A MyMyelomaTeam Member

With the current treatments this translocation is treatable. It depends whether or not you have other high risk genetics like 17p deletion, T53 double deletion or 13q.
Talk to your MM Specialist about this. A good resource is healthtree.org under Education. Also, you can sign up for a patient Coach who can answer many of your questions.

June 27
A MyMyelomaTeam Member

A t(14;16) mutation in multiple myeloma is indeed considered a high-risk cytogenetic feature. This means that the presence of this mutation can make the myeloma more resistant to treatment and may affect the overall prognosis. Here are some key points:

- High-Risk Cytogenetic Features: Certain gene changes, like t(14;16) read more

A t(14;16) mutation in multiple myeloma is indeed considered a high-risk cytogenetic feature. This means that the presence of this mutation can make the myeloma more resistant to treatment and may affect the overall prognosis. Here are some key points:

- High-Risk Cytogenetic Features: Certain gene changes, like t(14;16), are known to impact how well the myeloma responds to therapies.
- Impact on Treatment: These mutations can make the cancer more resistant to standard treatments, potentially leading to a shorter median overall survival.
- Personalized Treatment Plans: Oncologists often use the presence of such mutations to tailor treatment plans specifically to the patient's needs.

It's important to discuss your specific case with your oncologist, who can provide more personalized information and guidance.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Exposure to Radiation and the Risk for Myeloma | MyMyelomaTeam
Understanding Life Expectancy With Relapsed/Refractory Myeloma | MyMyelomaTeam
June 27

Related content

View All

Does Anyone Have A High Risk Mutation That Cause The Cancer To Come Out Of Remission Much Quicker?

A MyMyelomaTeam Member asked a question 💭
Tinton Falls, NJ
July 20, 2019

My Brother Had Agressive MM. He Went For 4 Chemo Session Then SCT And Then Another 4chemo Session. What His Chances Of Going In Remission?

A MyMyelomaTeam Member asked a question 💭
Los Angeles, CA
January 12 (edited)

I Have A High Risk Condition Called T14-16. Here Is My Fish Analysis Below. Based On This Info, Does This Sound Serious?

A MyMyelomaTeam Member asked a question 💭
Cincinnati, OH
September 30
FDA Approves Ketamine-Like Drug for Severe Depression
Multiple Myeloma Maintenance Therapy: 6 Facts
Stages of Multiple Myeloma
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in